enGene Therapeutics (ENGN) Other Accumulated Expenses (2023 - 2026)
enGene Therapeutics' Other Accumulated Expenses was $665,000 in fiscal Q3 2026 (quarter ended Jul 31, 2026), up 9.0% from $610,000 a year earlier but down 30.2% from the prior quarter.
Powered by 
Analysis
enGene Therapeutics (ENGN) Other Accumulated Expenses (2023 - 2026) Analysis & Trends
At the end of FY2025 (ended Oct 31, 2025), Other Accumulated Expenses at enGene Therapeutics came in at $577,000, up 156.4% from FY2024.
- In earlier fiscal years, Other Accumulated Expenses was $225,000 in FY2024 (+99.1%) and $113,000 in FY2023.
- Quarterly Other Accumulated Expenses has moved between $57,000 (fiscal Q1 2024) and $953,000 (fiscal Q2 2026) over five years.
- Compared with a year earlier, Other Accumulated Expenses was higher in seven of the last eight quarters, with growth averaging 163.6%.
- The best year-over-year quarter for Other Accumulated Expenses over five years was fiscal Q1 2025 (growth of 877.2%); the worst was fiscal Q1 2026 (a decline of 59.1%).
- Per Business Quant data, ENGN's Other Accumulated Expenses in the three fiscal quarters before Q3 2026 was $953,000 (Q2 2026), $228,000 (Q1 2026) and $577,000 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | enGene Therapeutics | 130.01 Mn | 130.01 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 665,000.00 |
| Apr 30, 2026 | 953,000.00 |
| Jan 31, 2026 | 228,000.00 |
| Oct 31, 2025 | 577,000.00 |
| Jul 31, 2025 | 610,000.00 |
| Apr 30, 2025 | 508,000.00 |
| Jan 31, 2025 | 557,000.00 |
| Oct 31, 2024 | 225,000.00 |
| Jul 31, 2024 | 403,000.00 |
| Apr 30, 2024 | 272,000.00 |
| Jan 31, 2024 | 57,000.00 |
| Oct 31, 2023 | 113,000.00 |
API Access
enGene Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();